» Articles » PMID: 21403036

Impact of Diabetes on Cardiovascular Disease Risk and All-cause Mortality in Older Men: Influence of Age at Onset, Diabetes Duration, and Established and Novel Risk Factors

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2011 Mar 16
PMID 21403036
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We have examined the influence of age at onset and duration on the impact of diabetes mellitus on cardiovascular disease risk and all cause-mortality among men aged 60 to 79 years.

Methods: A prospective study of 4045 men aged 60 to 79 years followed up for a mean of 9 years, during which there were 372 major coronary heart disease (CHD) events (fatal and nonfatal myocardial infarction [MI]), 455 deaths from cardiovascular disease, and 1112 deaths from all causes. Men were classified as having (1) no history of MI and diabetes, (2) late-onset diabetes (diagnosed at ≥60 years or undiagnosed diabetes [fasting blood glucose level, >126.1 mg/dL]), (3) early-onset diabetes (diagnosed before age 60 years), or (4) prior MI.

Results: Men who had both MI and diabetes were excluded. Both early and late onset of diabetes were associated with a significantly increased risk of major CHD events and all-cause mortality compared with nondiabetic men who had no CHD, even after adjustment for conventional risk factors and novel risk markers (levels of C-reactive protein and von Willebrand factor and renal dysfunction). Only men with early-onset diabetes (associated with a duration of 16.7 years) showed risk similar to those with previous MI and no diabetes. The adjusted relative risks (95% confidence intervals) for major CHD events were 1.00 (reference), 1.54 (1.07-2.21), 2.39 (1.41-4.05), and 2.51 (1.88-3.36) for groups 1 through 4, respectively.

Conclusion: Both early and late onset of diabetes are associated with increased risk of major CHD events and mortality, but only early onset of diabetes (associated with >10 years' duration) appears to be a CHD equivalent.

Citing Articles

Diabetes and the risk of cardiovascular events and all-cause mortality among older adults: an individual participant data analysis of five prospective studies.

Ribero V, Efthimiou O, Abolhassani N, Alwan H, Bauer D, Henrard S Eur J Clin Invest. 2024; 55(2):e14340.

PMID: 39465996 PMC: 11744924. DOI: 10.1111/eci.14340.


Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review.

Velidakis N, Stachteas P, Gkougkoudi E, Papadopoulos C, Kadoglou N Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794138 PMC: 11124492. DOI: 10.3390/ph17050568.


Ensemble machine learning reveals key features for diabetes duration from electronic health records.

Cerono G, Chicco D PeerJ Comput Sci. 2024; 10:e1896.

PMID: 38435625 PMC: 10909161. DOI: 10.7717/peerj-cs.1896.


A cross-sectional study in type 2 diabetes patients reveals that elevated pulse wave velocity predicts asymptomatic peripheral arterial disease associated with age and diabetes duration.

Gasparini D, Zuljani A, Wensveen F, Turk Wensveen T Int J Cardiol Heart Vasc. 2024; 49:101308.

PMID: 38173786 PMC: 10761307. DOI: 10.1016/j.ijcha.2023.101308.


The Impact of Statin Therapy on Cardiovascular Outcomes in Patients With Diabetes: A Systematic Review.

Usman N, Winson T, Basu Roy P, Tejani V, Dhillon S, Damarlapally N Cureus. 2023; 15(10):e47294.

PMID: 38021726 PMC: 10656369. DOI: 10.7759/cureus.47294.